BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 33075436)

  • 1. Codanin-1 mutations engineered in human erythroid cells demonstrate role of CDAN1 in terminal erythroid maturation.
    Murphy ZC; Getman MR; Myers JA; Burgos Villar KN; Leshen E; Kurita R; Nakamura Y; Steiner LA
    Exp Hematol; 2020 Nov; 91():32-38.e6. PubMed ID: 33075436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Codanin-1 mutations in congenital dyserythropoietic anemia type 1 affect HP1{alpha} localization in erythroblasts.
    Renella R; Roberts NA; Brown JM; De Gobbi M; Bird LE; Hassanali T; Sharpe JA; Sloane-Stanley J; Ferguson DJ; Cordell J; Buckle VJ; Higgs DR; Wood WG
    Blood; 2011 Jun; 117(25):6928-38. PubMed ID: 21364188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A complex comprising C15ORF41 and Codanin-1: the products of two genes mutated in congenital dyserythropoietic anaemia type I (CDA-I).
    Shroff M; Knebel A; Toth R; Rouse J
    Biochem J; 2020 May; 477(10):1893-1905. PubMed ID: 32239177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Congenital dyserythropoietic anemia type I is caused by mutations in codanin-1.
    Dgany O; Avidan N; Delaunay J; Krasnov T; Shalmon L; Shalev H; Eidelitz-Markus T; Kapelushnik J; Cattan D; Pariente A; Tulliez M; Crétien A; Schischmanoff PO; Iolascon A; Fibach E; Koren A; Rössler J; Le Merrer M; Yaniv I; Zaizov R; Ben-Asher E; Olender T; Lancet D; Beckmann JS; Tamary H
    Am J Hum Genet; 2002 Dec; 71(6):1467-74. PubMed ID: 12434312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Codanin-1, the protein encoded by the gene mutated in congenital dyserythropoietic anemia type I (CDAN1), is cell cycle-regulated.
    Noy-Lotan S; Dgany O; Lahmi R; Marcoux N; Krasnov T; Yissachar N; Ginsberg D; Motro B; Resnitzky P; Yaniv I; Kupfer GM; Tamary H
    Haematologica; 2009 May; 94(5):629-37. PubMed ID: 19336738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the interactions between Codanin-1 and C15Orf41, two proteins implicated in congenital dyserythropoietic anemia type I disease.
    Swickley G; Bloch Y; Malka L; Meiri A; Noy-Lotan S; Yanai A; Tamary H; Motro B
    BMC Mol Cell Biol; 2020 Mar; 21(1):18. PubMed ID: 32293259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recapitulation of erythropoiesis in congenital dyserythropoietic anaemia type I (CDA-I) identifies defects in differentiation and nucleolar abnormalities.
    Scott C; Downes DJ; Brown JM; Beagrie R; Olijnik AA; Gosden M; Schwessinger R; Fisher CA; Rose A; Ferguson DJP; Johnson E; Hill QA; Okoli S; Renella R; Ryan K; Brand M; Hughes J; Roy NBA; Higgs DR; Babbs C; Buckle VJ
    Haematologica; 2021 Nov; 106(11):2960-2970. PubMed ID: 33121234
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Noy-Lotan S; Dgany O; Marcoux N; Atkins A; Kupfer GM; Bosques L; Gottschalk C; Steinberg-Shemer O; Motro B; Tamary H
    Front Physiol; 2021; 12():685242. PubMed ID: 34234691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and functional insights into CDA-I prevalence and pathogenesis.
    Olijnik AA; Roy NBA; Scott C; Marsh JA; Brown J; Lauschke K; Ask K; Roberts N; Downes DJ; Brolih S; Johnson E; Xella B; Proven M; Hipkiss R; Ryan K; Frisk P; Mäkk J; Stattin EM; Sadasivam N; McIlwaine L; Hill QA; Renella R; Hughes JR; Gibbons RJ; Groth A; McHugh PJ; Higgs DR; Buckle VJ; Babbs C
    J Med Genet; 2021 Mar; 58(3):185-195. PubMed ID: 32518175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The congenital dyserythropoieitic anemias: genetics and pathophysiology.
    King R; Gallagher PJ; Khoriaty R
    Curr Opin Hematol; 2022 May; 29(3):126-136. PubMed ID: 35441598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Congenital dyserythropoietic anemia in a Chinese family with a mutation of the CDAN1-gene.
    Ru YX; Zhu XF; Yan WW; Gao JT; Schwarz K; Heimpel H
    Ann Hematol; 2008 Sep; 87(9):751-4. PubMed ID: 18575862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fetal presentation of congenital dyserythropoietic anemia type 1 with novel compound heterozygous CDAN1 mutations.
    Meznarich JA; Draper L; Christensen RD; Yaish HM; Luem ND; Pysher TJ; Jung G; Nemeth E; Ganz T; Ward DM
    Blood Cells Mol Dis; 2018 Jul; 71():63-66. PubMed ID: 29599085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and molecular variability in congenital dyserythropoietic anaemia type I.
    Tamary H; Dgany O; Proust A; Krasnov T; Avidan N; Eidelitz-Markus T; Tchernia G; Geneviève D; Cormier-Daire V; Bader-Meunier B; Ferrero-Vacher C; Munzer M; Gruppo R; Fibach E; Konen O; Yaniv I; Delaunay J
    Br J Haematol; 2005 Aug; 130(4):628-34. PubMed ID: 16098079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Congenital dyserythropoietic anemia type I with bone abnormalities, mutations of the CDAN I gene, and significant responsiveness to alpha-interferon therapy.
    Goede JS; Benz R; Fehr J; Schwarz K; Heimpel H
    Ann Hematol; 2006 Sep; 85(9):591-5. PubMed ID: 16767397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Congenital dyserythropoietic anemia in China: a case report from two families and a review.
    Ru Y; Liu G; Bai J; Dong S; Nie N; Zhang H; Zhao S; Zheng Y; Zhu X; Nie G; Zhang F; Eyden B
    Ann Hematol; 2014 May; 93(5):773-7. PubMed ID: 24196372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Congenital dyserythropoietic anemia type 1 with a novel mutation in the CDAN1 gene previously diagnosed as congenital hemolytic anemia.
    Fujino H; Doisaki S; Park YD; Hama A; Muramatsu H; Kojima S; Sumimoto S
    Int J Hematol; 2013 May; 97(5):650-3. PubMed ID: 23605369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KLF1 mutation E325K induces cell cycle arrest in erythroid cells differentiated from congenital dyserythropoietic anemia patient-specific induced pluripotent stem cells.
    Kohara H; Utsugisawa T; Sakamoto C; Hirose L; Ogawa Y; Ogura H; Sugawara A; Liao J; Aoki T; Iwasaki T; Asai T; Doisaki S; Okuno Y; Muramatsu H; Abe T; Kurita R; Miyamoto S; Sakuma T; Shiba M; Yamamoto T; Ohga S; Yoshida K; Ogawa S; Ito E; Kojima S; Kanno H; Tani K
    Exp Hematol; 2019 May; 73():25-37.e8. PubMed ID: 30876823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Congenital dyserythropoietic anaemia type II (HEMPAS) and its molecular basis.
    Fukuda MN
    Baillieres Clin Haematol; 1993 Jun; 6(2):493-511. PubMed ID: 8043936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Congenital dyserythropoietic anemias.
    Iolascon A; Russo R; Delaunay J
    Curr Opin Hematol; 2011 May; 18(3):146-51. PubMed ID: 21378561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Congenital dyserythropoietic anemias: molecular insights and diagnostic approach.
    Iolascon A; Heimpel H; Wahlin A; Tamary H
    Blood; 2013 Sep; 122(13):2162-6. PubMed ID: 23940284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.